文献速递胃肠外科

机器人远端胃切除术治疗胃癌的临床疗效与安全性:系统综述与Meta分析

Clinical efficacy and safety of robotic distal gastrectomy for gastric cancer: a systematic review and meta-analysis.
PubMed 文献 · Surg Endosc · 2022-01-12

本Meta分析纳入22项研究共5386例患者,比较机器人远端胃切除术(RDG)与腹腔镜远端胃切除术(LDG)。结果显示RDG手术时间更长,但术中出血更少、淋巴结检出数更多、胰瘘发生率更低;倾向性评分匹配后,首次排气时间和术后住院时间的差异失去显著性。RDG似乎可行且安全,在手术和肿瘤学结局方面优于LDG。

要点

  • RDG较LDG手术时间延长(MD=43.88,95%CI=35.17-52.60)。
  • RDG较LDG术中出血减少(MD=-24.84,95%CI=-41.26至-8.43)。
  • RDG较LDG胰瘘发生率更低(OR=0.23,95%CI=0.07-0.79)。

核心结论

  • 基于现有证据,RDG似乎可行且安全,手术和肿瘤学结局优于LDG,术后恢复和并发症结局相当。

研究设计与样本

  • 系统综述与Meta分析,检索PubMed、EMBASE、Cochrane Library和Web of Science从建库至2021年5月比较RDG与LDG的研究。
  • 共纳入22项研究涉及5386例患者,使用ROBIN-I评估观察性研究的偏倚风险,始终采用随机效应模型。

主要发现

  • 与LDG相比,RDG手术时间更长(MD=43.88,95%CI=35.17-52.60)。
  • RDG较LDG术中出血更少(MD=-24.84,95%CI=-41.26至-8.43),淋巴结检出数更多(MD=2.41,95%CI=0.77-4.05)。
  • RDG较LDG首次排气时间更短(MD=-0.09,95%CI=-0.15至-0.03),术后住院时间更短(MD=-0.68,95%CI=-1.27至-0.08)。
  • RDG较LDG胰瘘发生率更低(OR=0.23,95%CI=0.07-0.79)。
  • 近端和远端切缘距离、开始流质和软食时间及其他并发症在RDG与LDG组间无显著差异;倾向性评分匹配的Meta分析中,首次排气时间和术后住院时间的差异失去显著性。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Robotic distal gastrectomy (RDG) is a new technique that is rapidly gaining popularity and may help overcome the limitations of laparoscopic distal gastrectomy (LDG); however, its safety and therapeutic efficacy remain controversial. Therefore, this meta-analysis was performed to evaluate the safety and efficacy of RDG. METHODS: We searched PubMed, EMBASE, the Cochrane Library, and Web of Science for studies that compared RDG and LDG and were published between the time of database inception and May 2021. We assessed the bias risk of the observational studies using ROBIN-I, and a random effect model was always applied. RESULTS: The meta-analysis included 22 studies involving 5386 patients. Compared with LDG, RDG was associated with longer operating time (Mean Difference [MD] = 43.88, 95% CI = 35.17-52.60), less intraoperative blood loss (MD = - 24.84, 95% CI = - 41.26 to - 8.43), a higher number of retrieved lymph nodes (MD = 2.41, 95% CI = 0.77-4.05), shorter time to first flatus (MD = - 0.09, 95% CI = - 0.15 to - 0.03), shorter postoperative hospital stay (MD = - 0.68, 95% CI = - 1.27 to - 0.08), and lower incidence of pancreatic fistula (OR = 0.23, 95% CI = 0.07-0.79). Mean proximal and distal resection margin distances, time to start liquid and soft diets, and other complications were not significantly different between RDG and LDG groups. However, in the propensity-score-matched meta-analysis, the differences in time to first flatus and postoperative hospital stay between the two groups lost significance. CONCLUSIONS: Based on the available evidence, RDG appears feasible and safe, shows better surgical and oncological outcomes than LDG and, comparable postoperative recovery and postoperative complication outcomes.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Gong S, Li X, Tian H, et al. Clinical efficacy and safety of robotic distal gastrectomy for gastric cancer: a systematic review and meta-analysis. Surg Endosc. 2022. PMID: 35020057. doi:10.1007/s00464-021-08994-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。